Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2016

Mar 2, 2016

29875_dirs_2016-03-02_36b1192b-5ff7-4b52-ab1e-46d9f1b4bdf9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2016-02-29

Reporting Person: Boratto Eva C (SVP, Cont & Chief Acct Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-29 Common Stock A 2233 $97.17 Acquired 28795.4689 Direct
2016-02-29 Common Stock (restricted) A 1415 $97.17 Acquired 21310 Direct

Footnotes

F1: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.

F2: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2017.